Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-22
DOI
10.1007/s10549-018-4996-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss
- (2018) Yong-Yon Won et al. Dermatologic Therapy
- CME Part 2: Hair disorders in cancer survivors Persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, and hair growth disorders related to endocrine therapy or cancer surgery
- (2018) Azael Freites-Martinez et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- (2018) Azael Freites-Martinez et al. JAMA Dermatology
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- (2017) Athina Fonia et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Interventions for Female Pattern Hair Loss
- (2017) Esther J. van Zuuren et al. JAMA Dermatology
- Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries
- (2017) Mathias Meijer et al. Cancer Medicine
- Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
- (2016) Isla S. Mackenzie et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Abstract P1-15-04: Irriversible chemotherapy-induced alopecia in breast cancer patient
- (2016) S Kim et al. CANCER RESEARCH
- Abstract P5-17-04: Long term hair loss in patients with early breast cancer receiving docetaxel chemotherapy
- (2015) Nicola J Thorp et al. CANCER RESEARCH
- Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
- (2015) Cindy H. Chau et al. PLoS One
- Adjuvant Aromatase Inhibitor Therapy in Early Breast Cancer: What Factors Lead Patients to Discontinue Treatment?
- (2015) Luca Moscetti et al. TUMORI
- Adjuvant Aromatase Inhibitor Therapy in Early Breast Cancer: What Factors Lead Patients to Discontinue Treatment?
- (2015) Luca Moscetti et al. TUMORI JOURNAL
- Minoxidil may suppress androgen receptor-related functions
- (2015) Cheng-Lung Hsu et al. Oncotarget
- Hirsutism: An Evidence-Based Treatment Update
- (2014) Najwa Somani et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- (2014) Ruben G. Duijnhoven et al. CANCER CAUSES & CONTROL
- Abstract P3-09-15: Permanent chemotherapy induced alopecia in early breast cancer patients after (neo)adjuvant chemotherapy: Long term follow up
- (2014) M Bertrand et al. CANCER RESEARCH
- Aromatase inhibitors induce 'male pattern hair loss' in women?
- (2013) A. Rossi et al. ANNALS OF ONCOLOGY
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- (2013) Lisa Gallicchio et al. BREAST CANCER RESEARCH AND TREATMENT
- Spironolactone use and the risk of breast and gynecologic cancers
- (2013) Robert J. Biggar et al. Cancer Epidemiology
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- (2013) Mohd Ashraf Ganie et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride
- (2013) Aditya K Gupta et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- (2013) Steven T. Bird et al. JOURNAL OF UROLOGY
- Alopecia With Endocrine Therapies in Patients With Cancer
- (2013) V. Saggar et al. ONCOLOGIST
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- (2012) N. Kluger et al. ANNALS OF ONCOLOGY
- Hair: What is New in Diagnosis and Management?
- (2012) Natasha Atanaskova Mesinkovska et al. DERMATOLOGIC CLINICS
- Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study
- (2012) I. S. Mackenzie et al. BMJ-British Medical Journal
- Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: An update of what we now know
- (2011) Leona Yip et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Hormonal changes in menopause: do they contribute to a ‘midlife hair crisis’ in women?
- (2011) P. Mirmirani BRITISH JOURNAL OF DERMATOLOGY
- Pharmacogenetics of anti-estrogen treatment of breast cancer
- (2011) Marzia Del Re et al. CANCER TREATMENT REVIEWS
- Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia
- (2010) José Manuel Mella et al. ARCHIVES OF DERMATOLOGY
- Female pattern hair loss: beyond an androgenic aetiology?
- (2010) E.A. Langan et al. BRITISH JOURNAL OF DERMATOLOGY
- Innovative Use of Spironolactone as an Antiandrogen in the Treatment of Female Pattern Hair Loss
- (2010) Deepani Rathnayake et al. DERMATOLOGIC CLINICS
- 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss
- (2010) JH Yeon et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss
- (2009) L. Yip et al. BRITISH JOURNAL OF DERMATOLOGY
- Finasteride treatment for one year in 35 hirsute patients
- (2009) F. Bayram et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Hair Loss in Women
- (2009) Francisco M. Camacho-Martínez SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started